Loading...
OTCM
CSAMF
Market cap101mUSD
Jun 14, Last price  
4.82USD
Name

Csam Health Group AS

Chart & Performance

D1W1MN
P/E
P/S
2.40
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
425m
+3.53%
410,458,000424,959,000
Net income
-59m
L
104,350,000-59,290,000
CFO
132m
+239.82%
38,919,000132,254,000
Dividend
Apr 29, 20240.47693 USD/sh

Profile

CSAM Health Group AS provides various ehealth solutions in Norway and internationally. The company offers CSAM Arcidis, an integrated system for teleradiology; CSAM DICOM Server for handling radiology data; CSAM HelseMail for transfer of confidential patient data between healthcare organizations; CSAM Infobroker, a vendor-neutral telemedicine system for radiology that enables multiple clinicians to share resources and knowledge; CSAM S7, a platform for self-care and health counselling; CSAM Web Client, a web-based user interface and connectivity solution that allows users to access multiple CSAM applications and functions; and CSAM XDS, a central archive for storing and managing various types of clinical patient data. It also provides CSAM Cardio, an ECG and diagnostic storage tool; CSAM CIMA, a mobile application for capturing, using, and sending medical media; CSAM Media, a web-based medical imaging solution; CSAM Medimaker for image management and workflow solution; CSAM Picsara, an image management solution; and CSAM TRIS, a radiology information system. In addition, the company offers CSAM Partus, a maternity information system; CSAM Natus, a maternity care system; CSAM iPana Labor Information System, a web-based labour information system; CSAM iPana Maternity, a cloud-based service platform that enables expectant mothers, hospitals, and maternity clinics to electronically collect, store, and share medical information; and CSAM Fertsoft, a care and practice management software. Further, it provides CSAM Optima Predict solution for operational planning; CSAM Optima Live; CSAM AMIS, an emergency medical information system; CSAM IMTS, a tool for assessing and prioritizing patients; CSAM Paratus, an emergency response system; CSAM CoordCom; CSAM ResQMobile; CSAM Cytodose, an oncology management solution; and CSAM ProSang, an advanced laboratory information management system. The company was founded in 1999 and is headquartered in Oslo, Norway.
IPO date
Oct 09, 2020
Employees
Domiciled in
NO
Incorporated in
NO

Valuation

Title
NOK in thousands, except ratios and share amounts
FYFY
2024‑122023‑12
Income
Revenues
424,959
3.53%
410,458
 
Cost of revenue
31,032
53,761
Unusual Expense (Income)
NOPBT
393,927
356,697
NOPBT Margin
92.70%
86.90%
Operating Taxes
(789)
(8,353)
Tax Rate
NOPAT
394,716
365,050
Net income
(59,290)
-156.82%
104,350
 
Dividends
(9,741)
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
483,165
477,483
Deferred revenue
Other long-term liabilities
Net debt
361,307
363,687
Cash flow
Cash from operating activities
132,254
38,919
CAPEX
(44,036)
(46,359)
Cash from investing activities
(67,821)
(65,236)
Cash from financing activities
(65,854)
(55,087)
FCF
430,421
Balance
Cash
121,858
117,054
Long term investments
(3,258)
Excess cash
100,610
93,273
Stockholders' equity
2,097
2,097
Invested Capital
505,745
570,643
ROIC
73.34%
63.97%
ROCE
72.80%
59.30%
EV
Common stock shares outstanding
20,180
20,423
Price
Market cap
EV
EBITDA
449,993
291,272
EV/EBITDA
Interest
60,154
53,155
Interest/NOPBT
15.27%
14.90%